Celldex Therapeutics shares owned by Rock Springs Capital Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Rock Springs Capital Management
from 13F filings
Historical chart of Rock Springs Capital Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Rock Springs Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $19M | 722k | 25.87 |
| 2025-06-30 | $17M | 813k | 20.35 |
| 2025-03-31 | $15M | 813k | 18.15 |
| 2024-12-31 | $31M | 1.2M | 25.27 |
| 2024-09-30 | $38M | 1.1M | 33.99 |
| 2024-06-30 | $52M | 1.4M | 37.01 |
| 2024-03-31 | $58M | 1.4M | 41.97 |
| 2023-09-30 | $14M | 500k | 27.52 |
| 2023-06-30 | $14M | 422k | 33.93 |
| 2023-03-31 | $15M | 422k | 35.98 |
| 2022-12-31 | $19M | 422k | 44.57 |
| 2022-09-30 | $12M | 422k | 28.11 |
| 2022-06-30 | $9.0M | 336k | 26.96 |
| 2022-03-31 | $3.3M | 97k | 34.06 |
More positions owned by Rock Springs Capital Management
View all positions for Rock Springs Capital Management